To analyze the clinical value of contrast-enhanced ultrasound (CEUS) in the evaluation of patients with hepatocellular carcinoma (HCC) after thermal ablation.
Methods:
A total of 44 patients with HCC treated by radiofrequency ablation (19 cases) and microwave ablation (25 cases) were prospectively collected from May 2021 to November 2021 in De
partment of Hepatology and Interventional Surgery
Zhongshan Hospital Affiliated to Fudan University. The maximum diameter of the lesion was 9-42 mm
with an average of 18.1 mm. The thermal ablation of the lesion was guided by preoperative CEUS accurately. One month after the operation
CEUS and Gd-EOB-DTPA enhanced magnetic resonance imaging (MRI) were performed. The result of Gd-EOB- DTPA enhanced MRI examination was taken as the gold standard. The result of CEUS evaluation of thermal ablation treatment was compared with the gold standard. And the diagnostic coincidence rate of tumor inactivation by two imaging methods was analyzed.
Results:
After thermal ablation
there was no significant difference in lesion size between CEUS and Gd-EOB-DTPA enhanced MRI assessment (
P
=0.574). The Gd-EOB-DTPA enhanced MRI showed complete ablation in 40 cases and incomplete ablation in 4 cases. CEUS showed complete ablation in 41 cases and incomplete ablation in 3 cases. The accuracy
sensitivity and specificity of CEUS after operation were 97.7%
75.0% and 100.0%
respectively.
Conclusion:
CEUS has high accuracy
sensitivity and specificity in theevaluation of thermal ablation for HCC patients
and can be used to evaluating the efficacy of thermal ablation for HCC patients.